Drug interactions
Elivaldogene autotemcel + Tenofovir disoproxil
Severity: Major
Elivaldogene autotemcel and Tenofovir disoproxil: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Antiretrovirals can interfere with the manufacture of gene-modified autologous cell products by inhibiting lentiviral transduction. Tenofovir near cell collection may reduce product quality and efficacy.
What this interaction means in plain words
Elivaldogene autotemcel and Tenofovir disoproxil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Antiretroviral inhibition of lentiviral vector transduction of harvested cells during manufacturing.
What to do
Stop antiretrovirals at least one month before mobilization and until apheresis is complete. Coordinate the interruption with the HIV specialist.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Elivaldogene autotemcel and Tenofovir disoproxil, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Frequently asked questions
Can I take Elivaldogene autotemcel with Tenofovir disoproxil?
MediHelp rates the interaction as major. Elivaldogene autotemcel and Tenofovir disoproxil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Antiretrovirals can interfere with the manufacture of gene-modified autologous cell products by inhibiting lentiviral transduction. Tenofovir near cell collection may reduce product quality and efficacy.
How serious is the interaction between Elivaldogene autotemcel and Tenofovir disoproxil?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop antiretrovirals at least one month before mobilization and until apheresis is complete. Coordinate the interruption with the HIV specialist.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
